Thomas, McNerney & Partners II, LLC insider trades: Clarus Therapeutics (CRXT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Thomas, McNerney & Partners II, LLC reports to the SEC
Open-market buys and sales
12 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 20, 2022 | CRXT | ↓ Sell | 3,752,912 | $2.53 | $9.5M | Indirect | Apr 21, 2022 (1d) |
| Feb 11, 2015 | CASM | ↑ Buy | 1,591,037 | $1.30 | $2.1M | Direct | Feb 13, 2015 (2d) |
| Feb 11, 2015 | CASM | ↑ Buy | 8,025 | $1.30 | $10K | by TMP Nominee II, LLC | Feb 13, 2015 (2d) |
| Feb 11, 2015 | CASM | ↑ Buy | 5,938 | $1.30 | $8K | by TMP Associates II, LP | Feb 13, 2015 (2d) |
| Jan 28, 2015 | ASPX | ↓ Sell | 730,000 | $53.11 | $38.8M | Indirect | Jan 30, 2015 (2d) |
| Feb 10, 2014 | ASPX | ↑ Buy | 82,475 | $12.00 | $990K | Indirect | Oct 1, 2014 (233d) |
| Nov 29, 2010 | ZGNX | ↑ Buy | 524,229 | $4.00 | $2.1M | By Thomas, McNerney & Partners II, L.P. | Nov 30, 2010 (1d) |
| Nov 29, 2010 | ZGNX | ↑ Buy | 5,476 | $4.00 | $22K | By TMP Nominee II, LLC | Nov 30, 2010 (1d) |
| Nov 29, 2010 | ZGNX | ↑ Buy | 1,967 | $4.00 | $8K | By TMP Associates II, L.P. | Nov 30, 2010 (1d) |
| Nov 29, 2010 | ZGNX | ↑ Buy | 173,399 | $4.00 | $694K | Direct | Nov 29, 2010 (0d) |
| Nov 29, 2010 | ZGNX | ↑ Buy | 3,178 | $4.00 | $13K | By TMP Nominee, LLC | Nov 29, 2010 (0d) |
| Nov 29, 2010 | ZGNX | ↑ Buy | 647 | $4.00 | $3K | By TMP Associates, L.P. | Nov 29, 2010 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Thomas, McNerney & Partners II, LLC's insider trades
Thomas, McNerney & Partners II, LLC is a 10% owner of Clarus Therapeutics (CRXT). Since Nov 29, 2010, it has reported 10 open-market purchases worth $5.9M and 2 sales worth $48.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (5 filings), shares returned to the company (4 filings), option exercises (3 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CRXT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.